.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

MS Paris 2017 conference

EP. 1: Robert Zivadinov: The TOPIC Study's Key Takeaways

November 27th 2017

EP. 2: Bruce Cree: Long-Term Data Collection in MS Studies

November 27th 2017

EP. 3: Aaron Boster: Changing Dogma and Long-Term Data in MS

November 27th 2017

EP. 4: John Corboy: The DISCO-MS Trial and Halting Disease-Modifying Therapy

November 27th 2017

EP. 5: Francisco Quintana: The Need for New Candidate Therapies for MS

November 27th 2017

EP. 6: Martin Weber: Unmet Needs in MS and What We've Learned from NFL

November 27th 2017

Latest News

Jennifer Green, MD: Outcomes, Impact of SGLT2i, GLP-1 RA Combination Therapy

Joshua J. Joseph, MD: Managing CV Risk Factors in Patients with Type 2 Diabetes

Antirituximab Antibodies Detected in Patients with Pemphigus

View More News